nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—CYP2A6—Prednisolone—psoriatic arthritis	0.228	0.299	CbGbCtD
Montelukast—CYP2A6—Dexamethasone—psoriatic arthritis	0.134	0.176	CbGbCtD
Montelukast—CYP3A4—Methylprednisolone—psoriatic arthritis	0.071	0.0933	CbGbCtD
Montelukast—CYP2C8—Dexamethasone—psoriatic arthritis	0.0662	0.087	CbGbCtD
Montelukast—CYP3A4—Triamcinolone—psoriatic arthritis	0.0538	0.0707	CbGbCtD
Montelukast—CYP2C9—Dexamethasone—psoriatic arthritis	0.0462	0.0607	CbGbCtD
Montelukast—CYP3A4—Betamethasone—psoriatic arthritis	0.0461	0.0607	CbGbCtD
Montelukast—CYP3A4—Prednisolone—psoriatic arthritis	0.0455	0.0599	CbGbCtD
Montelukast—CYP3A4—Prednisone—psoriatic arthritis	0.043	0.0565	CbGbCtD
Montelukast—CYP3A4—Dexamethasone—psoriatic arthritis	0.0268	0.0353	CbGbCtD
Montelukast—Irritability—Dexamethasone—psoriatic arthritis	0.001	0.00419	CcSEcCtD
Montelukast—Irritability—Betamethasone—psoriatic arthritis	0.001	0.00419	CcSEcCtD
Montelukast—Influenza—Triamcinolone—psoriatic arthritis	0.001	0.00418	CcSEcCtD
Montelukast—Asthma—Triamcinolone—psoriatic arthritis	0.001	0.00418	CcSEcCtD
Montelukast—Injury—Prednisone—psoriatic arthritis	0.000995	0.00416	CcSEcCtD
Montelukast—Pancreatitis—Triamcinolone—psoriatic arthritis	0.000981	0.0041	CcSEcCtD
Montelukast—Pancreatitis—Methylprednisolone—psoriatic arthritis	0.000979	0.00409	CcSEcCtD
Montelukast—Bronchitis—Triamcinolone—psoriatic arthritis	0.000962	0.00402	CcSEcCtD
Montelukast—Neuropathy peripheral—Prednisolone—psoriatic arthritis	0.000951	0.00397	CcSEcCtD
Montelukast—Conjunctivitis—Prednisolone—psoriatic arthritis	0.000943	0.00394	CcSEcCtD
Montelukast—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.00093	0.00388	CcSEcCtD
Montelukast—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.00089	0.00372	CcSEcCtD
Montelukast—Infestation—Methylprednisolone—psoriatic arthritis	0.00089	0.00372	CcSEcCtD
Montelukast—Neuropathy peripheral—Triamcinolone—psoriatic arthritis	0.000875	0.00365	CcSEcCtD
Montelukast—Irritability—Prednisone—psoriatic arthritis	0.000873	0.00365	CcSEcCtD
Montelukast—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	0.000873	0.00364	CcSEcCtD
Montelukast—Conjunctivitis—Triamcinolone—psoriatic arthritis	0.000867	0.00362	CcSEcCtD
Montelukast—Epistaxis—Triamcinolone—psoriatic arthritis	0.000842	0.00351	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.000807	0.00337	CcSEcCtD
Montelukast—Rhinitis—Triamcinolone—psoriatic arthritis	0.000803	0.00335	CcSEcCtD
Montelukast—Rhinitis—Methylprednisolone—psoriatic arthritis	0.000801	0.00334	CcSEcCtD
Montelukast—Hallucination—Methylprednisolone—psoriatic arthritis	0.000795	0.00332	CcSEcCtD
Montelukast—Pharyngitis—Triamcinolone—psoriatic arthritis	0.000795	0.00332	CcSEcCtD
Montelukast—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.000794	0.00331	CcSEcCtD
Montelukast—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.000794	0.00331	CcSEcCtD
Montelukast—Conjunctivitis—Dexamethasone—psoriatic arthritis	0.000787	0.00329	CcSEcCtD
Montelukast—Conjunctivitis—Betamethasone—psoriatic arthritis	0.000787	0.00329	CcSEcCtD
Montelukast—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000785	0.00328	CcSEcCtD
Montelukast—Pancreatitis—Prednisone—psoriatic arthritis	0.000775	0.00324	CcSEcCtD
Montelukast—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000742	0.0031	CcSEcCtD
Montelukast—Irritability—Methotrexate—psoriatic arthritis	0.00073	0.00305	CcSEcCtD
Montelukast—Hallucination—Dexamethasone—psoriatic arthritis	0.000723	0.00302	CcSEcCtD
Montelukast—Hallucination—Betamethasone—psoriatic arthritis	0.000723	0.00302	CcSEcCtD
Montelukast—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000722	0.00301	CcSEcCtD
Montelukast—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00072	0.00301	CcSEcCtD
Montelukast—Mental disorder—Methylprednisolone—psoriatic arthritis	0.0007	0.00292	CcSEcCtD
Montelukast—Angioedema—Prednisolone—psoriatic arthritis	0.000693	0.00289	CcSEcCtD
Montelukast—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.000691	0.00289	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.000689	0.00287	CcSEcCtD
Montelukast—Asthma—Methotrexate—psoriatic arthritis	0.000661	0.00276	CcSEcCtD
Montelukast—Convulsion—Prednisolone—psoriatic arthritis	0.000657	0.00274	CcSEcCtD
Montelukast—Eosinophilia—Methotrexate—psoriatic arthritis	0.000654	0.00273	CcSEcCtD
Montelukast—Pancreatitis—Methotrexate—psoriatic arthritis	0.000648	0.0027	CcSEcCtD
Montelukast—Angioedema—Triamcinolone—psoriatic arthritis	0.000637	0.00266	CcSEcCtD
Montelukast—Angioedema—Methylprednisolone—psoriatic arthritis	0.000636	0.00265	CcSEcCtD
Montelukast—Hallucination—Prednisone—psoriatic arthritis	0.00063	0.00263	CcSEcCtD
Montelukast—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000622	0.0026	CcSEcCtD
Montelukast—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000619	0.00258	CcSEcCtD
Montelukast—Oedema—Prednisolone—psoriatic arthritis	0.000619	0.00258	CcSEcCtD
Montelukast—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000614	0.00256	CcSEcCtD
Montelukast—Cough—Triamcinolone—psoriatic arthritis	0.000608	0.00254	CcSEcCtD
Montelukast—Convulsion—Triamcinolone—psoriatic arthritis	0.000604	0.00252	CcSEcCtD
Montelukast—Convulsion—Methylprednisolone—psoriatic arthritis	0.000603	0.00252	CcSEcCtD
Montelukast—Myalgia—Triamcinolone—psoriatic arthritis	0.000594	0.00248	CcSEcCtD
Montelukast—Pneumonia—Methotrexate—psoriatic arthritis	0.000593	0.00247	CcSEcCtD
Montelukast—Myalgia—Methylprednisolone—psoriatic arthritis	0.000592	0.00247	CcSEcCtD
Montelukast—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000592	0.00247	CcSEcCtD
Montelukast—Anxiety—Methylprednisolone—psoriatic arthritis	0.00059	0.00246	CcSEcCtD
Montelukast—Infestation—Methotrexate—psoriatic arthritis	0.000589	0.00246	CcSEcCtD
Montelukast—Infestation NOS—Methotrexate—psoriatic arthritis	0.000589	0.00246	CcSEcCtD
Montelukast—Drowsiness—Methotrexate—psoriatic arthritis	0.000589	0.00246	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000588	0.00246	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000584	0.00244	CcSEcCtD
Montelukast—Angioedema—Dexamethasone—psoriatic arthritis	0.000578	0.00241	CcSEcCtD
Montelukast—Angioedema—Betamethasone—psoriatic arthritis	0.000578	0.00241	CcSEcCtD
Montelukast—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000573	0.00239	CcSEcCtD
Montelukast—Immune system disorder—Prednisone—psoriatic arthritis	0.000572	0.00239	CcSEcCtD
Montelukast—Oedema—Triamcinolone—psoriatic arthritis	0.000569	0.00238	CcSEcCtD
Montelukast—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000569	0.00238	CcSEcCtD
Montelukast—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000568	0.00237	CcSEcCtD
Montelukast—Infection—Triamcinolone—psoriatic arthritis	0.000565	0.00236	CcSEcCtD
Montelukast—Infection—Methylprednisolone—psoriatic arthritis	0.000564	0.00235	CcSEcCtD
Montelukast—Insomnia—Prednisolone—psoriatic arthritis	0.00056	0.00234	CcSEcCtD
Montelukast—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000557	0.00233	CcSEcCtD
Montelukast—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000557	0.00232	CcSEcCtD
Montelukast—Epistaxis—Methotrexate—psoriatic arthritis	0.000556	0.00232	CcSEcCtD
Montelukast—Paraesthesia—Prednisolone—psoriatic arthritis	0.000556	0.00232	CcSEcCtD
Montelukast—Mental disorder—Prednisone—psoriatic arthritis	0.000555	0.00231	CcSEcCtD
Montelukast—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000552	0.0023	CcSEcCtD
Montelukast—Convulsion—Betamethasone—psoriatic arthritis	0.000548	0.00229	CcSEcCtD
Montelukast—Convulsion—Dexamethasone—psoriatic arthritis	0.000548	0.00229	CcSEcCtD
Montelukast—Myalgia—Betamethasone—psoriatic arthritis	0.000539	0.00225	CcSEcCtD
Montelukast—Myalgia—Dexamethasone—psoriatic arthritis	0.000539	0.00225	CcSEcCtD
Montelukast—Anxiety—Dexamethasone—psoriatic arthritis	0.000537	0.00224	CcSEcCtD
Montelukast—Anxiety—Betamethasone—psoriatic arthritis	0.000537	0.00224	CcSEcCtD
Montelukast—Pain—Prednisolone—psoriatic arthritis	0.000529	0.00221	CcSEcCtD
Montelukast—Hepatitis—Methotrexate—psoriatic arthritis	0.000529	0.00221	CcSEcCtD
Montelukast—Pharyngitis—Methotrexate—psoriatic arthritis	0.000525	0.00219	CcSEcCtD
Montelukast—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000522	0.00218	CcSEcCtD
Montelukast—Urethral disorder—Methotrexate—psoriatic arthritis	0.000519	0.00216	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000518	0.00216	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000517	0.00216	CcSEcCtD
Montelukast—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000516	0.00216	CcSEcCtD
Montelukast—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000516	0.00216	CcSEcCtD
Montelukast—Oedema—Betamethasone—psoriatic arthritis	0.000516	0.00216	CcSEcCtD
Montelukast—Oedema—Dexamethasone—psoriatic arthritis	0.000516	0.00216	CcSEcCtD
Montelukast—Insomnia—Triamcinolone—psoriatic arthritis	0.000515	0.00215	CcSEcCtD
Montelukast—Insomnia—Methylprednisolone—psoriatic arthritis	0.000514	0.00214	CcSEcCtD
Montelukast—Infection—Dexamethasone—psoriatic arthritis	0.000513	0.00214	CcSEcCtD
Montelukast—Infection—Betamethasone—psoriatic arthritis	0.000513	0.00214	CcSEcCtD
Montelukast—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000511	0.00213	CcSEcCtD
Montelukast—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00051	0.00213	CcSEcCtD
Montelukast—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000506	0.00211	CcSEcCtD
Montelukast—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000506	0.00211	CcSEcCtD
Montelukast—Agitation—Prednisone—psoriatic arthritis	0.000506	0.00211	CcSEcCtD
Montelukast—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000506	0.00211	CcSEcCtD
Montelukast—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000506	0.00211	CcSEcCtD
Montelukast—Angioedema—Prednisone—psoriatic arthritis	0.000503	0.0021	CcSEcCtD
Montelukast—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000501	0.00209	CcSEcCtD
Montelukast—Erythema multiforme—Methotrexate—psoriatic arthritis	0.0005	0.00209	CcSEcCtD
Montelukast—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.0005	0.00209	CcSEcCtD
Montelukast—Urticaria—Prednisolone—psoriatic arthritis	0.000492	0.00205	CcSEcCtD
Montelukast—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000491	0.00205	CcSEcCtD
Montelukast—Fatigue—Triamcinolone—psoriatic arthritis	0.000491	0.00205	CcSEcCtD
Montelukast—Fatigue—Methylprednisolone—psoriatic arthritis	0.00049	0.00204	CcSEcCtD
Montelukast—Pain—Triamcinolone—psoriatic arthritis	0.000487	0.00203	CcSEcCtD
Montelukast—Immune system disorder—Methotrexate—psoriatic arthritis	0.000478	0.00199	CcSEcCtD
Montelukast—Convulsion—Prednisone—psoriatic arthritis	0.000477	0.00199	CcSEcCtD
Montelukast—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000477	0.00199	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00047	0.00196	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00047	0.00196	CcSEcCtD
Montelukast—Arthralgia—Prednisone—psoriatic arthritis	0.000469	0.00196	CcSEcCtD
Montelukast—Myalgia—Prednisone—psoriatic arthritis	0.000469	0.00196	CcSEcCtD
Montelukast—Anxiety—Prednisone—psoriatic arthritis	0.000467	0.00195	CcSEcCtD
Montelukast—Insomnia—Betamethasone—psoriatic arthritis	0.000467	0.00195	CcSEcCtD
Montelukast—Insomnia—Dexamethasone—psoriatic arthritis	0.000467	0.00195	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000466	0.00194	CcSEcCtD
Montelukast—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000464	0.00194	CcSEcCtD
Montelukast—Paraesthesia—Betamethasone—psoriatic arthritis	0.000464	0.00194	CcSEcCtD
Montelukast—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000464	0.00194	CcSEcCtD
Montelukast—Mental disorder—Methotrexate—psoriatic arthritis	0.000463	0.00193	CcSEcCtD
Montelukast—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000456	0.0019	CcSEcCtD
Montelukast—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000455	0.0019	CcSEcCtD
Montelukast—Dyspepsia—Betamethasone—psoriatic arthritis	0.000455	0.0019	CcSEcCtD
Montelukast—Urticaria—Triamcinolone—psoriatic arthritis	0.000452	0.00189	CcSEcCtD
Montelukast—Urticaria—Methylprednisolone—psoriatic arthritis	0.000451	0.00188	CcSEcCtD
Montelukast—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00045	0.00188	CcSEcCtD
Montelukast—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00045	0.00188	CcSEcCtD
Montelukast—Oedema—Prednisone—psoriatic arthritis	0.00045	0.00188	CcSEcCtD
Montelukast—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000449	0.00187	CcSEcCtD
Montelukast—Infection—Prednisone—psoriatic arthritis	0.000447	0.00186	CcSEcCtD
Montelukast—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000446	0.00186	CcSEcCtD
Montelukast—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000446	0.00186	CcSEcCtD
Montelukast—Fatigue—Dexamethasone—psoriatic arthritis	0.000445	0.00186	CcSEcCtD
Montelukast—Fatigue—Betamethasone—psoriatic arthritis	0.000445	0.00186	CcSEcCtD
Montelukast—Pain—Dexamethasone—psoriatic arthritis	0.000442	0.00184	CcSEcCtD
Montelukast—Pain—Betamethasone—psoriatic arthritis	0.000442	0.00184	CcSEcCtD
Montelukast—Nervous system disorder—Prednisone—psoriatic arthritis	0.000441	0.00184	CcSEcCtD
Montelukast—Skin disorder—Prednisone—psoriatic arthritis	0.000437	0.00182	CcSEcCtD
Montelukast—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000422	0.00176	CcSEcCtD
Montelukast—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000422	0.00176	CcSEcCtD
Montelukast—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000419	0.00175	CcSEcCtD
Montelukast—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000418	0.00175	CcSEcCtD
Montelukast—Urticaria—Betamethasone—psoriatic arthritis	0.00041	0.00171	CcSEcCtD
Montelukast—Urticaria—Dexamethasone—psoriatic arthritis	0.00041	0.00171	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00041	0.00171	CcSEcCtD
Montelukast—Dizziness—Prednisolone—psoriatic arthritis	0.000409	0.00171	CcSEcCtD
Montelukast—Asthenia—Triamcinolone—psoriatic arthritis	0.000408	0.0017	CcSEcCtD
Montelukast—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000408	0.0017	CcSEcCtD
Montelukast—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000408	0.0017	CcSEcCtD
Montelukast—Abdominal pain—Betamethasone—psoriatic arthritis	0.000408	0.0017	CcSEcCtD
Montelukast—Body temperature increased—Betamethasone—psoriatic arthritis	0.000408	0.0017	CcSEcCtD
Montelukast—Asthenia—Methylprednisolone—psoriatic arthritis	0.000407	0.0017	CcSEcCtD
Montelukast—Insomnia—Prednisone—psoriatic arthritis	0.000407	0.0017	CcSEcCtD
Montelukast—Paraesthesia—Prednisone—psoriatic arthritis	0.000404	0.00169	CcSEcCtD
Montelukast—Pruritus—Triamcinolone—psoriatic arthritis	0.000403	0.00168	CcSEcCtD
Montelukast—Cough—Methotrexate—psoriatic arthritis	0.000402	0.00168	CcSEcCtD
Montelukast—Pruritus—Methylprednisolone—psoriatic arthritis	0.000402	0.00168	CcSEcCtD
Montelukast—Convulsion—Methotrexate—psoriatic arthritis	0.000399	0.00167	CcSEcCtD
Montelukast—Dyspepsia—Prednisone—psoriatic arthritis	0.000396	0.00165	CcSEcCtD
Montelukast—Arthralgia—Methotrexate—psoriatic arthritis	0.000392	0.00164	CcSEcCtD
Montelukast—Myalgia—Methotrexate—psoriatic arthritis	0.000392	0.00164	CcSEcCtD
Montelukast—Rash—Prednisolone—psoriatic arthritis	0.00039	0.00163	CcSEcCtD
Montelukast—Dermatitis—Prednisolone—psoriatic arthritis	0.00039	0.00163	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000389	0.00163	CcSEcCtD
Montelukast—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000389	0.00162	CcSEcCtD
Montelukast—Fatigue—Prednisone—psoriatic arthritis	0.000388	0.00162	CcSEcCtD
Montelukast—Headache—Prednisolone—psoriatic arthritis	0.000388	0.00162	CcSEcCtD
Montelukast—Dizziness—Triamcinolone—psoriatic arthritis	0.000376	0.00157	CcSEcCtD
Montelukast—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000376	0.00157	CcSEcCtD
Montelukast—Dizziness—Methylprednisolone—psoriatic arthritis	0.000375	0.00157	CcSEcCtD
Montelukast—Infection—Methotrexate—psoriatic arthritis	0.000373	0.00156	CcSEcCtD
Montelukast—Asthenia—Dexamethasone—psoriatic arthritis	0.00037	0.00155	CcSEcCtD
Montelukast—Asthenia—Betamethasone—psoriatic arthritis	0.00037	0.00155	CcSEcCtD
Montelukast—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000369	0.00154	CcSEcCtD
Montelukast—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000368	0.00154	CcSEcCtD
Montelukast—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000368	0.00154	CcSEcCtD
Montelukast—Nausea—Prednisolone—psoriatic arthritis	0.000368	0.00153	CcSEcCtD
Montelukast—Pruritus—Dexamethasone—psoriatic arthritis	0.000365	0.00153	CcSEcCtD
Montelukast—Pruritus—Betamethasone—psoriatic arthritis	0.000365	0.00153	CcSEcCtD
Montelukast—Skin disorder—Methotrexate—psoriatic arthritis	0.000365	0.00152	CcSEcCtD
Montelukast—Vomiting—Triamcinolone—psoriatic arthritis	0.000362	0.00151	CcSEcCtD
Montelukast—Vomiting—Methylprednisolone—psoriatic arthritis	0.000361	0.00151	CcSEcCtD
Montelukast—Rash—Triamcinolone—psoriatic arthritis	0.000359	0.0015	CcSEcCtD
Montelukast—Dermatitis—Triamcinolone—psoriatic arthritis	0.000358	0.0015	CcSEcCtD
Montelukast—Rash—Methylprednisolone—psoriatic arthritis	0.000358	0.00149	CcSEcCtD
Montelukast—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000358	0.00149	CcSEcCtD
Montelukast—Urticaria—Prednisone—psoriatic arthritis	0.000357	0.00149	CcSEcCtD
Montelukast—Headache—Triamcinolone—psoriatic arthritis	0.000357	0.00149	CcSEcCtD
Montelukast—Headache—Methylprednisolone—psoriatic arthritis	0.000356	0.00148	CcSEcCtD
Montelukast—Abdominal pain—Prednisone—psoriatic arthritis	0.000355	0.00148	CcSEcCtD
Montelukast—Body temperature increased—Prednisone—psoriatic arthritis	0.000355	0.00148	CcSEcCtD
Montelukast—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000353	0.00147	CcSEcCtD
Montelukast—Diarrhoea—Betamethasone—psoriatic arthritis	0.000353	0.00147	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000342	0.00143	CcSEcCtD
Montelukast—Dizziness—Dexamethasone—psoriatic arthritis	0.000341	0.00143	CcSEcCtD
Montelukast—Dizziness—Betamethasone—psoriatic arthritis	0.000341	0.00143	CcSEcCtD
Montelukast—Insomnia—Methotrexate—psoriatic arthritis	0.00034	0.00142	CcSEcCtD
Montelukast—Nausea—Triamcinolone—psoriatic arthritis	0.000338	0.00141	CcSEcCtD
Montelukast—Paraesthesia—Methotrexate—psoriatic arthritis	0.000337	0.00141	CcSEcCtD
Montelukast—Nausea—Methylprednisolone—psoriatic arthritis	0.000337	0.00141	CcSEcCtD
Montelukast—Somnolence—Methotrexate—psoriatic arthritis	0.000334	0.00139	CcSEcCtD
Montelukast—Hypersensitivity—Prednisone—psoriatic arthritis	0.000331	0.00138	CcSEcCtD
Montelukast—Dyspepsia—Methotrexate—psoriatic arthritis	0.000331	0.00138	CcSEcCtD
Montelukast—Vomiting—Betamethasone—psoriatic arthritis	0.000328	0.00137	CcSEcCtD
Montelukast—Vomiting—Dexamethasone—psoriatic arthritis	0.000328	0.00137	CcSEcCtD
Montelukast—Rash—Betamethasone—psoriatic arthritis	0.000326	0.00136	CcSEcCtD
Montelukast—Rash—Dexamethasone—psoriatic arthritis	0.000326	0.00136	CcSEcCtD
Montelukast—Dermatitis—Betamethasone—psoriatic arthritis	0.000325	0.00136	CcSEcCtD
Montelukast—Dermatitis—Dexamethasone—psoriatic arthritis	0.000325	0.00136	CcSEcCtD
Montelukast—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000324	0.00135	CcSEcCtD
Montelukast—Fatigue—Methotrexate—psoriatic arthritis	0.000324	0.00135	CcSEcCtD
Montelukast—Headache—Dexamethasone—psoriatic arthritis	0.000323	0.00135	CcSEcCtD
Montelukast—Headache—Betamethasone—psoriatic arthritis	0.000323	0.00135	CcSEcCtD
Montelukast—Asthenia—Prednisone—psoriatic arthritis	0.000323	0.00135	CcSEcCtD
Montelukast—Pain—Methotrexate—psoriatic arthritis	0.000321	0.00134	CcSEcCtD
Montelukast—Pruritus—Prednisone—psoriatic arthritis	0.000318	0.00133	CcSEcCtD
Montelukast—Diarrhoea—Prednisone—psoriatic arthritis	0.000308	0.00128	CcSEcCtD
Montelukast—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000307	0.00128	CcSEcCtD
Montelukast—Nausea—Betamethasone—psoriatic arthritis	0.000307	0.00128	CcSEcCtD
Montelukast—Nausea—Dexamethasone—psoriatic arthritis	0.000307	0.00128	CcSEcCtD
Montelukast—Urticaria—Methotrexate—psoriatic arthritis	0.000299	0.00125	CcSEcCtD
Montelukast—Dizziness—Prednisone—psoriatic arthritis	0.000297	0.00124	CcSEcCtD
Montelukast—Abdominal pain—Methotrexate—psoriatic arthritis	0.000297	0.00124	CcSEcCtD
Montelukast—Body temperature increased—Methotrexate—psoriatic arthritis	0.000297	0.00124	CcSEcCtD
Montelukast—Vomiting—Prednisone—psoriatic arthritis	0.000286	0.00119	CcSEcCtD
Montelukast—Rash—Prednisone—psoriatic arthritis	0.000284	0.00118	CcSEcCtD
Montelukast—Dermatitis—Prednisone—psoriatic arthritis	0.000283	0.00118	CcSEcCtD
Montelukast—Headache—Prednisone—psoriatic arthritis	0.000282	0.00118	CcSEcCtD
Montelukast—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000277	0.00116	CcSEcCtD
Montelukast—Asthenia—Methotrexate—psoriatic arthritis	0.00027	0.00113	CcSEcCtD
Montelukast—Nausea—Prednisone—psoriatic arthritis	0.000267	0.00112	CcSEcCtD
Montelukast—Pruritus—Methotrexate—psoriatic arthritis	0.000266	0.00111	CcSEcCtD
Montelukast—Diarrhoea—Methotrexate—psoriatic arthritis	0.000257	0.00107	CcSEcCtD
Montelukast—Dizziness—Methotrexate—psoriatic arthritis	0.000249	0.00104	CcSEcCtD
Montelukast—Vomiting—Methotrexate—psoriatic arthritis	0.000239	0.000997	CcSEcCtD
Montelukast—Rash—Methotrexate—psoriatic arthritis	0.000237	0.000989	CcSEcCtD
Montelukast—Dermatitis—Methotrexate—psoriatic arthritis	0.000237	0.000988	CcSEcCtD
Montelukast—Headache—Methotrexate—psoriatic arthritis	0.000235	0.000983	CcSEcCtD
Montelukast—Nausea—Methotrexate—psoriatic arthritis	0.000223	0.000932	CcSEcCtD
